Buflomedil
| Code | Size | Price |
|---|
| TAR-T0317L-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Buflomedil is a vasoactive compound. Buflomedil has been used for peripheral arterial diseases.
CAS:
55837-25-7
Formula:
C17H25NO4
Molecular Weight:
307.39
Purity:
0.98
SMILES:
COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1
References
1. de Backer TL, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD000988. doi: 10.1002/14651858.CD000988.pub4. Review. PubMed PMID: 23543509.
2. Bucolo C, Longo L, Camillieri G, Drago F, Salomone S. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011. Pharmacoepidemiol Drug Saf. 2012 Nov;21(11):1190-6. doi: 10.1002/pds.3328. Epub 2012 Jul 31. Review. PubMed PMID: 22855302.
3. Tsantilas D, Hatzitolios AI, Tziomalos K, Karamitsos D, Papadimitriou D. Effects of buflomedil on skin blood flow in patients with type 2 diabetes mellitus without overt micro- or macroangiopathy. Int Angiol. 2011 Apr;30(2):164-71. PubMed PMID: 21427654.
4. Wu S, Zeng Q, Liu M, Yang J, He S, Lin S, Wu B. Buflomedil for acute ischaemic stroke. Cochrane Database Syst Rev. 2015 Jul 20;(7):CD009570. doi: 10.1002/14651858.CD009570.pub2. Review. PubMed PMID: 26193704.